Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, ...
News Medical on MSN17h
IgE antibodies show promise in targeting HER2 cancers resistant to other therapiesAntibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.
In this episode of Targeted Talks, Alfred L. Garfall, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback